Alpha 2.0
Login Register
» Authors » Barnett Kramer

Barnett Kramer

Explore the profile of Barnett Kramer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 336
Followers 0
Related Specialties
General Medicine
Oncology
Public Health
Top 10 Co-Authors
Steven Woloshin
Derek Raghavan
Richard Fagerstrom
Philip Prorok
Raymond Sawaya
Helen Macdonald
Kirsten McCaffery
Maurie Markman
David Pfister
Paul Pinsky
Published In
J Clin Oncol
BMJ
Chest
Epidemiology
Clin Gastroenterol Hepatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Results of the cancer screening feasibility study in China: a multicentered randomized controlled trial of lung and colorectal cancer screening
Li J, Hu P, Shi J, Fan Y, Ren J, Chen H, et al.
J Natl Cancer Cent . 2024 Jul; 1(4):132-138. PMID: 39036801
Background: To provide an understanding of important aspects of the participant recruitment and data collection, become aware of any potential problems, and obtain necessary information in order to design a...
2.
Call to improve transparent communication in direct-to-consumer test marketing
Gram E, Macdonald H, Kramer B, Woloshin S
BMJ Evid Based Med . 2024 Jun; 29(4):213-214. PMID: 38937068
No abstract available.
3.
Overdiagnosis and too much medicine in a world of crises
Kuhlein T, Macdonald H, Kramer B, Johansson M, Woloshin S, McCaffery K, et al.
BMJ . 2023 Aug; 382:1865. PMID: 37573032
No abstract available.
4.
Overdiagnosis: it's official
Woloshin S, Kramer B
BMJ . 2021 Nov; 375:n2854. PMID: 34799371
No abstract available.
5.
5α-Reductase Inhibitor Use in Patients With Prostate Cancer
Thompson Jr I, Tangen C, Kramer B
JAMA Intern Med . 2019 Oct; 179(10):1440. PMID: 31589258
No abstract available.
6.
Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis
McCaffery K, Nickel B, Pickles K, Moynihan R, Kramer B, Barratt A, et al.
BMJ Open . 2019 May; 9(5):e026960. PMID: 31122983
Objective: To describe the lived experience of a possible prostate cancer overdiagnosis in men who resisted recommended treatment. Design: Qualitative interview study SETTING: Australia PARTICIPANTS: 11 men (aged 59-78 years)...
7.
Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline
Visvanathan K, Hurley P, Bantug E, Brown P, Col N, Cuzick J, et al.
J Clin Oncol . 2013 Jul; 31(23):2942-62. PMID: 23835710
Purpose: To update the 2009 American Society of Clinical Oncology guideline on pharmacologic interventions for breast cancer (BC) risk reduction. Methods: A systematic review of randomized controlled trials and meta-analyses...
8.
Current status of the National Children's Study
Hirschfeld S, Kramer B, Guttmacher A
Epidemiology . 2010 Jul; 21(5):605-6. PMID: 20631619
No abstract available.
9.
Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Petrelli N, Winer E, Brahmer J, Dubey S, Smith S, Thomas C, et al.
J Clin Oncol . 2009 Nov; 27(35):6052-69. PMID: 19901123
No abstract available.
10.
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L, et al.
J Clin Oncol . 2008 Dec; 27(5):812-26. PMID: 19103723
A message from ASCO'S president: Nearly 40 years ago, President Richard Nixon signed the National Cancer Act, mobilizing the country's resources to make the "conquest of cancer a national crusade."...